Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Rowan Hardy, Karim Raza, Mark S. Cooper
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 3, pp. 133-144
Open Access | Times Cited: 204

Showing 1-25 of 204 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 402
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong, Jungen Tang, Cong Ye, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 7, pp. e428-e436
Open Access | Times Cited: 237
Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder
Noriyoshi Usui, Hikaru Kobayashi, Shoichi Shimada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5487-5487
Open Access | Times Cited: 95
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis
Maria Chiara Bruno, Maria Chiara Cristiano, Christian Celia, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 19665-19690
Closed Access | Times Cited: 87
DNA Origami as a Nanomedicine for Targeted Rheumatoid Arthritis Therapy through Reactive Oxygen Species and Nitric Oxide Scavenging
Yuxuan Ma, Zhangwei Lu, Bin Jia, et al.
ACS Nano (2022) Vol. 16, Iss. 8, pp. 12520-12531
Open Access | Times Cited: 77
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids
Jean-Philippe Auger, Max Zimmermann, Maria M. Faas, et al.
Nature (2024) Vol. 629, Iss. 8010, pp. 184-192
Closed Access | Times Cited: 53
An Antioxidant Enzyme Therapeutic for COVID‐19
Meng Qin, Zheng Cao, Jing Wen, et al.
Advanced Materials (2020) Vol. 32, Iss. 43
Open Access | Times Cited: 87
Pharmacologic activities of phytosteroids in inflammatory diseases: Mechanism of action and therapeutic potentials
Rishab Marahatha, Kabita Gyawali, Kabita Sharma, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 5103-5124
Closed Access | Times Cited: 63
The role of neutrophils in rheumatic disease-associated vascular inflammation
Lihui Wang, Raashid Luqmani, Irina A. Udalova
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 3, pp. 158-170
Closed Access | Times Cited: 59
Chiral Selenium Nanotherapeutics Regulates Selenoproteins to Attenuate Glucocorticoid‐Induced Osteoporosis
Zushuang Xiong, Hao Lin, Hong Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 17
Closed Access | Times Cited: 27
The role of targeting glucose metabolism in chondrocytes in the pathogenesis and therapeutic mechanisms of osteoarthritis: a narrative review
Peng Pi, Liqing Zeng, Zhipeng Zeng, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 12
An anti–TNF–glucocorticoid receptor modulator antibody-drug conjugate is efficacious against immune-mediated inflammatory diseases
Michael Mcpherson, Adrian D. Hobson, Axel Hernandez, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 739
Closed Access | Times Cited: 8
Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss
Wenyu Fu, Meng Chen, Kaidi Wang, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 23-44
Open Access | Times Cited: 1
Understanding the molecular bridges between the drugs and immune cell
Umesh Chandra Dash, Vinayak Nayak, Hiten Shanker Navani, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108805-108805
Open Access | Times Cited: 1
Approaches towards fighting the COVID‑19 pandemic (Review)
Shih‐Chang Tsai, Chi‐Cheng Lu, DA-TIAN BAU, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 3-22
Open Access | Times Cited: 68
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
Carlos Rafael‐Vidal, Nair Pérez, Irene Altabás, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7100-7100
Open Access | Times Cited: 56
Significantly Improving the Bioefficacy for Rheumatoid Arthritis with Supramolecular Nanoformulations
Chao Ma, Bo Li, Jinrui Zhang, et al.
Advanced Materials (2021) Vol. 33, Iss. 16
Closed Access | Times Cited: 55
Early Research on COVID-19: A Bibliometric Analysis
Yue Gong, Tingcan Ma, Yangyang Xu, et al.
The Innovation (2020) Vol. 1, Iss. 2, pp. 100027-100027
Open Access | Times Cited: 54
Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Dulce Peris-Moreno, Laura Cussonneau, Lydie Combaret, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 407-407
Open Access | Times Cited: 54
Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search
Nadia M T Roodenrijs, Paco M J Welsing, Joël van Roon, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 9, pp. 3552-3566
Open Access | Times Cited: 36
Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review
Nanette L. A. Vincken, Deepak M.W. Balak, André C. Knulst, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 11, pp. 4232-4244
Open Access | Times Cited: 28
Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
Mikkel Bo Brent
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108383-108383
Open Access | Times Cited: 19
Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase
Evelyn Bracho-Sanchez, Fernanda Regina Godoy Rocha, Sean K. Bedingfield, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1156-1169
Open Access | Times Cited: 16
Unintended Consequences: Risk of Opportunistic Infections Associated With Long-term Glucocorticoid Therapies in Adults
Daniel B. Chastain, Megan Spradlin, Hiba Ahmad, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. e37-e56
Open Access | Times Cited: 16
Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
Chenyang Lu, Shasha Li, Yi Liu
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 737-739
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top